Clinical Trial Update: SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for SCT-I10A plus standard chemotherapy in first-line recurrent/metastatic head and neck squamous cell carcinoma is in progress wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• SCT-I10A

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 3 | Status: UNKNOWN